Showing results 1 to 20 of 23
next >
| Issue Date | Title | Author(s) |
| 23-Dec-2022 | Asprosin Exerts Pro-Inflammatory Effects in THP-1 Macrophages Mediated via the Toll-like Receptor 4 (TLR4) Pathway | Shabir, K; Gharanei, S; Orton, S; Patel, V; Chauhan, P; Karteris, E; Randeva, HS; Brown, JE; Kyrou, I |
| 26-Feb-2021 | COVID‑19 and SARS‑CoV‑2 host cell entry mediators: Expression profiling of TMRSS4 in health and disease | Katopodis, P; Kerslake, R; Davies, J; Randeva, HS; Chatha, K; Hall, M; Spandidos, DA; Anikin, V; Polychronis, A; Robertus, JL; Kyrou, I; Karteris, E |
| 2020 | Co‑expression of peripheral olfactory receptors with SARS‑CoV‑2 infection mediators: Potential implications beyond loss of smell as a COVID‑19 symptom | Kerslake, R; Hall, M; Randeva, H; Spandidos, D; Chatha, K; Kyrou, I; Karteris, E |
| 1-Feb-2022 | Differential Expression of RAD51AP1 in Ovarian Cancer: Effects of siRNA In Vitro | Filipe, A; Chudasama, D; Kerslake, R; Jeyaneethi, J; Anikin, V; Kyrou, I; Randeva, H; Sisu, C; Hall, M; Karteris, E |
| 8-Oct-2022 | Differential Regulation of Genes by the Glucogenic Hormone Asprosin in Ovarian Cancer | Kerslake, R; Sisu, C; Panfilov, S; Hall, M; Khan, N; Jeyaneethi, J; Randeva, H; Kyrou, I; Karteris, E |
| 22-Feb-2022 | The effect of online and in-person team-based learning (TBL) on undergraduate endocrinology teaching during COVID-19 pandemic | Anas, S; Kyrou, I; Rand-Weaver, M; Karteris, E |
| 27-Dec-2022 | Elevated Circulating Lactate Levels and Widespread Expression of Its Cognate Receptor, Hydroxycarboxylic Acid Receptor 1 (HCAR1), in Ovarian Cancer | Kerslake, R; Panfilov, S; Mustafa, N; Hall, M; Kyrou, I; Randeva, H; Karteris, E; Godfrey, R |
| 2018 | Functional Cardiac Orexin Receptors: Role of Orexin-B/Orexin 2 Receptor in Myocardial Protection. | Karteris, E; Patel, VH; Chen, J; Kyrou, I; Mattu, H; Dimitriadis, G; Rodrigo, G; Antoniades, C; Antonopoulos, A; Tan, B; Hillhouse, E; Ng, A; Randeva, H |
| 20-Dec-2021 | Host cell entry mediators implicated in the cellular tropism of SARS‑CoV‑2, the pathophysiology of COVID‑19 and the identification of microRNAs that can modulate the expression of these mediators (Review) | Katopodis, P; Randeva, HS; Spandidos, DA; Saravi, S; Kyrou, I; Karteris, E |
| 10-May-2022 | Impact of environmentally relevant concentrations of Bisphenol A (BPA) on the gene expression profile in an in vitro model of the normal human ovary | Zahra, A; Kerslake, R; Kyrou, I; Randeva, HS; Sisu, C; Karteris, E |
| 30-Jan-2024 | In Silico and In Vitro Mapping of Receptor-Type Protein Tyrosine Phosphatase Receptor Type D in Health and Disease: Implications for Asprosin Signalling in Endometrial Cancer and Neuroblastoma | Orton, S; Karkia, R; Mustafov, D; Gharanei, S; Braoudaki, M; Filipe, A; Panfilov, S; Saravi, S; Khan, N; Kyrou, I; Karteris, E; Chatterjee, J; Randeva, HS |
| 3-Feb-2020 | Involvement of the Endocrine-Disrupting Chemical Bisphenol A (BPA) in Human Placentation | de Aguiar Greca, S-C; Kyrou, I; Pink, R; Randeva, H; Grammatopoulos, D; Silva, E; Karteris, E |
| 2018 | Involvement of the glutamine RF-amide peptide (QRFP) and its cognate receptor GPR103 in prostate cancer | Karteris, E; Kawan, M; Kyrou, I; Ramanjaneya, M; Williams, K; Jeyaneethi, J; Randeva, H |
| 14-Oct-2020 | Is there a link between bisphenol A (BPA), a key endocrine disruptor, and the risk for SARS-CoV-2 infection and severe COVID-19? | Zahra, A; Sisu, C; Silva, E; De Aguiar Greca, S-C; Randeva, H; Chatha, K; Kyrou, I; Karteris, E |
| 8-Dec-2022 | A Meta-analysis of 2D vs. 3D Ovarian Cancer Cellular Models | Kerslake, R; Belay, B; Panfilov, S; Hall, M; Kyrou, I; Randeva, HS; Hyttinen, J; Karteris, E; Sisu, C |
| 15-Sep-2020 | Neuropilin‑1 as a new potential SARS‑CoV‑2 infection mediator implicated in the neurologic features and central nervous system involvement of COVID‑19 | Davies, J; Randeva, HS; Chatha, K; Hall, M; Spandidos, DA; Karteris, E; Kyrou, I |
| 18-Jan-2021 | Not only ACE2—the quest for additional host cell mediators of SARS-CoV-2 infection: Neuropilin-1 (NRP1) as a novel SARS-CoV-2 host cell entry mediator implicated in COVID-19 | Kyrou, I; Randeva, HS; Spandidos, DA; Karteris, E |
| 28-Mar-2022 | NUCB2/Nesfatin-1 Reduces Obesogenic Diet Induced Inflammation in Mice Subcutaneous White Adipose Tissue | Gharanei, S; Ramanjaneya, M; Patel, AH; Patel, V; Shabir, K; Auld, C; Karteris, E; Kyrou, I; Randeva, HS |
| 9-Jul-2021 | A pancancer overview of FBN1, asprosin and its cognate receptor OR4M1 with detailed expression profiling in ovarian cancer | Kerslake, R; Hall, M; Vagnarelli, P; Jeyaneethi, J; Randeva, HS; Pados, G; Kyrou, I; Karteris, E |
| 26-May-2020 | Pan‑cancer analysis of transmembrane protease serine 2 and cathepsin L that mediate cellular SARS‑CoV‑2 infection leading to COVID-19 | Katopodis, P; Anikin, V; Randeva, H; Spandidos, D; Chatha, K; Kyrou, I; Karteris, E |
